Status: current, Defined. Date: 31-Mar 2022. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4965102012 | Product containing precisely metformin hydrochloride 850 milligram and sitagliptin (as sitagliptin phosphate) 50 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
4965103019 | Metformin hydrochloride 850 mg and sitagliptin (as sitagliptin phosphate) 50 mg oral tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Metformin hydrochloride 850 mg and sitagliptin (as sitagliptin phosphate) 50 mg oral tablet | Is a | Metformin and sitagliptin only product in oral dose form | true | Inferred relationship | Some | ||
Metformin hydrochloride 850 mg and sitagliptin (as sitagliptin phosphate) 50 mg oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Some | ||
Metformin hydrochloride 850 mg and sitagliptin (as sitagliptin phosphate) 50 mg oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Some | ||
Metformin hydrochloride 850 mg and sitagliptin (as sitagliptin phosphate) 50 mg oral tablet | Has precise active ingredient | Metformin hydrochloride | true | Inferred relationship | Some | 1 | |
Metformin hydrochloride 850 mg and sitagliptin (as sitagliptin phosphate) 50 mg oral tablet | Has BoSS | Metformin hydrochloride | true | Inferred relationship | Some | 1 | |
Metformin hydrochloride 850 mg and sitagliptin (as sitagliptin phosphate) 50 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Metformin hydrochloride 850 mg and sitagliptin (as sitagliptin phosphate) 50 mg oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 1 | |
Metformin hydrochloride 850 mg and sitagliptin (as sitagliptin phosphate) 50 mg oral tablet | Has precise active ingredient | Sitagliptin phosphate | true | Inferred relationship | Some | 2 | |
Metformin hydrochloride 850 mg and sitagliptin (as sitagliptin phosphate) 50 mg oral tablet | Has BoSS | Sitagliptin | true | Inferred relationship | Some | 2 | |
Metformin hydrochloride 850 mg and sitagliptin (as sitagliptin phosphate) 50 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Metformin hydrochloride 850 mg and sitagliptin (as sitagliptin phosphate) 50 mg oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 2 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets